PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23821376-0	2014	Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT.	Oxaliplatin	134-145	tumor protein p53	Homo sapiens	29-33	
23821376-10	2014	Patients with KRAS/NRAS, BRAF and TP53 wild-type tumours could derive the maximal benefits from treatment with cetuximab, oxaliplatin and UFT.	Oxaliplatin	122-133	tumor protein p53	Homo sapiens	34-38